Clearside Biomedical, Inc. (CLSDQ) › Net IncomeClearside Biomedical, Inc. (CLSDQ) — Net IncomeAnnual figures by fiscal year, from SEC filings.2014: -$10.19M2015: -$17.64M2016: -$25.88M2017: -$58.98M2018: -$82.82M2019: -$30.77M2020: -$18.21M2021: $376.0K2022: -$32.95M2023: -$32.48M2024: -$34.35M-$34.35M2014Net Income (USD)2024Fiscal YearNet IncomeChange YoY2024-$34.35M-5.7%2023-$32.48M+1.4%2022-$32.95M-8862.5%2021$376.0K+102.1%2020-$18.21M+40.8%2019-$30.77M+62.8%2018-$82.82M-40.4%2017-$58.98M-127.9%2016-$25.88M-46.7%2015-$17.64M-73.1%2014-$10.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share